Rockwell Medical, Inc. (RMTI) — SEC Filings
Rockwell Medical, Inc. (RMTI) — 29 SEC filings. Latest: 8-K (May 7, 2026). Includes 15 8-K, 6 10-Q, 3 10-K.
View Rockwell Medical, Inc. on SEC EDGAR
Overview
Rockwell Medical, Inc. (RMTI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a ARS filed on Apr 30, 2026: Rockwell Medical, Inc. filed its Annual Report to Security Holders (ARS) on April 30, 2026, for the period ending December 31, 2025. The company is located at 30142 Wixom Road, Wixom, MI 48393. The filing is a standard annual report and does not contain specific financial figures or significant even
Sentiment Summary
Across 29 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 25 neutral, 1 mixed. The dominant filing sentiment for Rockwell Medical, Inc. is neutral.
Filing Type Overview
Rockwell Medical, Inc. (RMTI) has filed 15 8-K, 1 ARS, 3 10-K, 6 10-Q, 2 DEF 14A, 2 SC 13G/A with the SEC between Jan 2024 to May 2026.
Filings by Year
Recent SEC Filings (29)
Risk Profile
Risk Assessment: Of RMTI's 21 recent filings, 2 were flagged as high-risk, 10 as medium-risk, and 9 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Key Executives
- Heather Hunter
- Rashad Brown
- Joe Dawson
- Dr. Robert L. Johnson
- Ms. Sarah Chen
- Dr. Robert L. Judd
- Ms. Karen L. King
- Mr. David M. D. Smith
Industry Context
Rockwell Medical operates within the U.S. hemodialysis concentrates market, which is experiencing steady growth, projected to increase from $450 million in 2024 to $560 million by 2028. This market is characterized by the critical need for reliable and safe dialysis solutions for patients with end-stage kidney disease. Key players supply essential concentrates and related products to a network of dialysis centers and providers.
Top Tags
10-Q (4) · Hemodialysis (3) · Medical Devices (3) · management-change (3) · corporate-governance (3) · financials (3) · annual-report (2) · Operational Efficiency (2) · 8-K (2) · board-of-directors (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Period of Report | 2025-12-31 | The end date for the reporting period covered by the ARS. |
| Filing Date | 2026-04-30 | The date Rockwell Medical, Inc. submitted this ARS filing. |
| Aggregate market value of nonvoting common equity held by nonaffiliates | $28,688,982 | as of June 30, 2025 |
| Shares outstanding of Common Stock | 39,405,302 | as of March 23, 2026 |
| Projected U.S. hemodialysis concentrates market size | $560 million | by 2028, up from $450 million in 2024 |
| New customers added in the western U.S. | 30 | in Q4 2025, increasing western U.S. footprint to over 10% |
| Total customers | 294 | including all five leading U.S. dialysis providers |
| Size of new single-use bicarbonate cartridge | 720 grams | one of two sizes introduced in February 2025 |
| Individual purchasing facilities in the U.S. | 12,000 | market opportunity for Rockwell Medical |
| Year DaVita agreement extended to | 2026 | through December 31, 2026, with increased product pricing |
| Year manufacturing concluded at South Carolina facility | 2025 | in the third quarter, for operational streamlining |
| Net Sales | $50.912M | Decreased from $76.824M for the nine months ended September 30, 2024 |
| Net Loss | $(4.760)M | Compared to net income of $0.276M for the nine months ended September 30, 2024 |
| Net Cash Used In Operating Activities | $(2.950)M | For the nine months ended September 30, 2025, compared to $3.337M provided in 2024 |
| Cash and Cash Equivalents | $13.610M | As of September 30, 2025, down from $15.662M at December 31, 2024 |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Rockwell Medical, Inc. (RMTI)?
Rockwell Medical, Inc. has 29 recent SEC filings from Jan 2024 to May 2026, including 15 8-K, 6 10-Q, 3 10-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of RMTI filings?
Across 29 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 25 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Rockwell Medical, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Rockwell Medical, Inc. (RMTI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Rockwell Medical, Inc.?
Key financial highlights from Rockwell Medical, Inc.'s most recent 10-K include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for RMTI?
The investment thesis for RMTI includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Rockwell Medical, Inc.?
Key executives identified across Rockwell Medical, Inc.'s filings include Heather Hunter, Rashad Brown, Joe Dawson, Dr. Robert L. Johnson, Ms. Sarah Chen and 3 others.
What are the main risk factors for Rockwell Medical, Inc. stock?
Of RMTI's 21 assessed filings, 2 were flagged high-risk, 10 medium-risk, and 9 low-risk.
What are recent predictions and forward guidance from Rockwell Medical, Inc.?
Forward guidance and predictions for Rockwell Medical, Inc. are extracted from SEC filings as they are enriched.